APO Research
Talk to an analyst

APO RESEARCH · REPORT

Propofol Injection for Operation General Anesthesia

Compare research editions
View pricing & licenses

Selected research

Industry Research

Propofol Injection for Operation General Anesthesia Industry Research Report 2026

22 December 2025121 pages

Choose your research edition.

Industry ResearchPropofol Injection for Operation General Anesthesia Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Propofol Injection for Operation General Anesthesia Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Propofol Injection for Operation General Anesthesia Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Propofol Injection for Operation General Anesthesia Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Propofol Injection for Operation General Anesthesia Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Propofol Injection for Operation General Anesthesia market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Propofol Injection for Operation General Anesthesia is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Propofol Injection for Operation General Anesthesia is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Propofol Injection for Operation General Anesthesia is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Propofol Injection for Operation General Anesthesia include Yichang Humanwell, Xi'an Libang, Nhwa, Hengrui, China National Medicines Guorui Pharmaceutical Co.,Ltd., Fresenius-Kabi, Baxter Healthcare, AbbVie and AstraZeneca, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Propofol Injection for Operation General Anesthesia market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Propofol Injection for Operation General Anesthesia Market by Company

Yichang Humanwell

Xi'an Libang

Nhwa

Hengrui

China National Medicines Guorui Pharmaceutical Co.,Ltd.

Fresenius-Kabi

Baxter Healthcare

AbbVie

AstraZeneca

Piramal

Maruishi

Hikma Pharmaceuticals

B.Braun

Aspen Pharma

Propofol Injection for Operation General Anesthesia Segment by Type

10ml

20ml

50ml

Others

Propofol Injection for Operation General Anesthesia Segment by Application

Hopitals

Clinics

Others

Propofol Injection for Operation General Anesthesia Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Propofol Injection for Operation General Anesthesia market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Propofol Injection for Operation General Anesthesia and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Propofol Injection for Operation General Anesthesia.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Propofol Injection for Operation General Anesthesia manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Propofol Injection for Operation General Anesthesia by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Propofol Injection for Operation General Anesthesia in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Propofol Injection for Operation General Anesthesia Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Propofol Injection for Operation General Anesthesia Sales (k units) of Manufacturers (2021-2026) Table 7. Global Propofol Injection for Operation General Anesthesia Sales Market Share by Manufacturers (2021-2026) Table 8. Global Propofol Injection for Operation General Anesthesia Revenue of Manufacturers (2021-2026) Table 9. Global Propofol Injection for Operation General Anesthesia Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Propofol Injection for Operation General Anesthesia Average Price (US$/unit) of Manufacturers (2021-2026) Table 11. Global Propofol Injection for Operation General Anesthesia Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Propofol Injection for Operation General Anesthesia, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Propofol Injection for Operation General Anesthesia, Product Type & Application Table 14. Global Propofol Injection for Operation General Anesthesia Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Propofol Injection for Operation General Anesthesia by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Yichang Humanwell Company Information Table 19. Yichang Humanwell Business Overview Table 20. Yichang Humanwell Propofol Injection for Operation General Anesthesia Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 21. Yichang Humanwell Propofol Injection for Operation General Anesthesia Product Portfolio Table 22. Yichang Humanwell Recent Developments Table 23. Xi'an Libang Company Information Table 24. Xi'an Libang Business Overview Table 25. Xi'an Libang Propofol Injection for Operation General Anesthesia Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 26. Xi'an Libang Propofol Injection for Operation General Anesthesia Product Portfolio Table 27. Xi'an Libang Recent Developments Table 28. Nhwa Company Information Table 29. Nhwa Business Overview Table 30. Nhwa Propofol Injection for Operation General Anesthesia Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 31. Nhwa Propofol Injection for Operation General Anesthesia Product Portfolio Table 32. Nhwa Recent Developments Table 33. Hengrui Company Information Table 34. Hengrui Business Overview Table 35. Hengrui Propofol Injection for Operation General Anesthesia Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 36. Hengrui Propofol Injection for Operation General Anesthesia Product Portfolio Table 37. Hengrui Recent Developments Table 38. China National Medicines Guorui Pharmaceutical Co.,Ltd. Company Information Table 39. China National Medicines Guorui Pharmaceutical Co.,Ltd. Business Overview Table 40. China National Medicines Guorui Pharmaceutical Co.,Ltd. Propofol Injection for Operation General Anesthesia Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 41. China National Medicines Guorui Pharmaceutical Co.,Ltd. Propofol Injection for Operation General Anesthesia Product Portfolio Table 42. China National Medicines Guorui Pharmaceutical Co.,Ltd. Recent Developments Table 43. Fresenius-Kabi Company Information Table 44. Fresenius-Kabi Business Overview Table 45. Fresenius-Kabi Propofol Injection for Operation General Anesthesia Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 46. Fresenius-Kabi Propofol Injection for Operation General Anesthesia Product Portfolio Table 47. Fresenius-Kabi Recent Developments Table 48. Baxter Healthcare Company Information Table 49. Baxter Healthcare Business Overview Table 50. Baxter Healthcare Propofol Injection for Operation General Anesthesia Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 51. Baxter Healthcare Propofol Injection for Operation General Anesthesia Product Portfolio Table 52. Baxter Healthcare Recent Developments Table 53. AbbVie Company Information Table 54. AbbVie Business Overview Table 55. AbbVie Propofol Injection for Operation General Anesthesia Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 56. AbbVie Propofol Injection for Operation General Anesthesia Product Portfolio Table 57. AbbVie Recent Developments Table 58. AstraZeneca Company Information Table 59. AstraZeneca Business Overview Table 60. AstraZeneca Propofol Injection for Operation General Anesthesia Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 61. AstraZeneca Propofol Injection for Operation General Anesthesia Product Portfolio Table 62. AstraZeneca Recent Developments Table 63. Piramal Company Information Table 64. Piramal Business Overview Table 65. Piramal Propofol Injection for Operation General Anesthesia Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 66. Piramal Propofol Injection for Operation General Anesthesia Product Portfolio Table 67. Piramal Recent Developments Table 68. Maruishi Company Information Table 69. Maruishi Business Overview Table 70. Maruishi Propofol Injection for Operation General Anesthesia Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 71. Maruishi Propofol Injection for Operation General Anesthesia Product Portfolio Table 72. Maruishi Recent Developments Table 73. Hikma Pharmaceuticals Company Information Table 74. Hikma Pharmaceuticals Business Overview Table 75. Hikma Pharmaceuticals Propofol Injection for Operation General Anesthesia Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 76. Hikma Pharmaceuticals Propofol Injection for Operation General Anesthesia Product Portfolio Table 77. Hikma Pharmaceuticals Recent Developments Table 78. B.Braun Company Information Table 79. B.Braun Business Overview Table 80. B.Braun Propofol Injection for Operation General Anesthesia Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 81. B.Braun Propofol Injection for Operation General Anesthesia Product Portfolio Table 82. B.Braun Recent Developments Table 83. Aspen Pharma Company Information Table 84. Aspen Pharma Business Overview Table 85. Aspen Pharma Propofol Injection for Operation General Anesthesia Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 86. Aspen Pharma Propofol Injection for Operation General Anesthesia Product Portfolio Table 87. Aspen Pharma Recent Developments Table 88. Global Propofol Injection for Operation General Anesthesia Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 89. Global Propofol Injection for Operation General Anesthesia Sales by Region (2021-2026) & (k units) Table 90. Global Propofol Injection for Operation General Anesthesia Sales Market Share by Region (2021-2026) Table 91. Global Propofol Injection for Operation General Anesthesia Sales by Region (2027-2032) & (k units) Table 92. Global Propofol Injection for Operation General Anesthesia Sales Market Share by Region (2027-2032) Table 93. Global Propofol Injection for Operation General Anesthesia Revenue by Region (2021-2026) & (US$ Million) Table 94. Global Propofol Injection for Operation General Anesthesia Revenue Market Share by Region (2021-2026) Table 95. Global Propofol Injection for Operation General Anesthesia Revenue by Region (2027-2032) & (US$ Million) Table 96. Global Propofol Injection for Operation General Anesthesia Revenue Market Share by Region (2027-2032) Table 97. North America Propofol Injection for Operation General Anesthesia Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 98. North America Propofol Injection for Operation General Anesthesia Sales by Country (2021-2026) & (k units) Table 99. North America Propofol Injection for Operation General Anesthesia Sales by Country (2027-2032) & (k units) Table 100. North America Propofol Injection for Operation General Anesthesia Revenue by Country (2021-2026) & (US$ Million) Table 101. North America Propofol Injection for Operation General Anesthesia Revenue by Country (2027-2032) & (US$ Million) Table 102. Europe Propofol Injection for Operation General Anesthesia Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 103. Europe Propofol Injection for Operation General Anesthesia Sales by Country (2021-2026) & (k units) Table 104. Europe Propofol Injection for Operation General Anesthesia Sales by Country (2027-2032) & (k units) Table 105. Europe Propofol Injection for Operation General Anesthesia Revenue by Country (2021-2026) & (US$ Million) Table 106. Europe Propofol Injection for Operation General Anesthesia Revenue by Country (2027-2032) & (US$ Million) Table 107. Asia Pacific Propofol Injection for Operation General Anesthesia Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 108. Asia Pacific Propofol Injection for Operation General Anesthesia Sales by Country (2021-2026) & (k units) Table 109. Asia Pacific Propofol Injection for Operation General Anesthesia Sales by Country (2027-2032) & (k units) Table 110. Asia Pacific Propofol Injection for Operation General Anesthesia Revenue by Country (2021-2026) & (US$ Million) Table 111. Asia Pacific Propofol Injection for Operation General Anesthesia Revenue by Country (2027-2032) & (US$ Million) Table 112. South America Propofol Injection for Operation General Anesthesia Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 113. South America Propofol Injection for Operation General Anesthesia Sales by Country (2021-2026) & (k units) Table 114. South America Propofol Injection for Operation General Anesthesia Sales by Country (2027-2032) & (k units) Table 115. South America Propofol Injection for Operation General Anesthesia Revenue by Country (2021-2026) & (US$ Million) Table 116. South America Propofol Injection for Operation General Anesthesia Revenue by Country (2027-2032) & (US$ Million) Table 117. Middle East and Africa Propofol Injection for Operation General Anesthesia Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 118. Middle East and Africa Propofol Injection for Operation General Anesthesia Sales by Country (2021-2026) & (k units) Table 119. Middle East and Africa Propofol Injection for Operation General Anesthesia Sales by Country (2027-2032) & (k units) Table 120. Middle East and Africa Propofol Injection for Operation General Anesthesia Revenue by Country (2021-2026) & (US$ Million) Table 121. Middle East and Africa Propofol Injection for Operation General Anesthesia Revenue by Country (2027-2032) & (US$ Million) Table 122. Global Propofol Injection for Operation General Anesthesia Sales by Type (2021-2026) & (k units) Table 123. Global Propofol Injection for Operation General Anesthesia Sales by Type (2027-2032) & (k units) Table 124. Global Propofol Injection for Operation General Anesthesia Sales Market Share by Type (2021-2026) Table 125. Global Propofol Injection for Operation General Anesthesia Sales Market Share by Type (2027-2032) Table 126. Global Propofol Injection for Operation General Anesthesia Revenue by Type (2021-2026) & (US$ Million) Table 127. Global Propofol Injection for Operation General Anesthesia Revenue by Type (2027-2032) & (US$ Million) Table 128. Global Propofol Injection for Operation General Anesthesia Revenue Market Share by Type (2021-2026) Table 129. Global Propofol Injection for Operation General Anesthesia Revenue Market Share by Type (2027-2032) Table 130. Global Propofol Injection for Operation General Anesthesia Price by Type (2021-2026) & (US$/unit) Table 131. Global Propofol Injection for Operation General Anesthesia Price by Type (2027-2032) & (US$/unit) Table 132. Global Propofol Injection for Operation General Anesthesia Sales by Application (2021-2026) & (k units) Table 133. Global Propofol Injection for Operation General Anesthesia Sales by Application (2027-2032) & (k units) Table 134. Global Propofol Injection for Operation General Anesthesia Sales Market Share by Application (2021-2026) Table 135. Global Propofol Injection for Operation General Anesthesia Sales Market Share by Application (2027-2032) Table 136. Global Propofol Injection for Operation General Anesthesia Revenue by Application (2021-2026) & (US$ Million) Table 137. Global Propofol Injection for Operation General Anesthesia Revenue by Application (2027-2032) & (US$ Million) Table 138. Global Propofol Injection for Operation General Anesthesia Revenue Market Share by Application (2021-2026) Table 139. Global Propofol Injection for Operation General Anesthesia Revenue Market Share by Application (2027-2032) Table 140. Global Propofol Injection for Operation General Anesthesia Price by Application (2021-2026) & (US$/unit) Table 141. Global Propofol Injection for Operation General Anesthesia Price by Application (2027-2032) & (US$/unit) Table 142. Key Raw Materials Table 143. Raw Materials Key Suppliers Table 144. Propofol Injection for Operation General Anesthesia Distributors List Table 145. Propofol Injection for Operation General Anesthesia Customers List Table 146. Propofol Injection for Operation General Anesthesia Industry Trends Table 147. Propofol Injection for Operation General Anesthesia Industry Drivers Table 148. Propofol Injection for Operation General Anesthesia Industry Restraints Table 149. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Propofol Injection for Operation General Anesthesia Product Image Figure 5. Global Propofol Injection for Operation General Anesthesia Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Propofol Injection for Operation General Anesthesia Market Size (2021-2032) & (US$ Million) Figure 7. Global Propofol Injection for Operation General Anesthesia Sales (2021-2032) & (k units) Figure 8. Global Propofol Injection for Operation General Anesthesia Average Price (US$/unit) & (2021-2032) Figure 9. 10ml Product Image Figure 10. 20ml Product Image Figure 11. 50ml Product Image Figure 12. Others Product Image Figure 13. Hopitals Product Image Figure 14. Clinics Product Image Figure 15. Others Product Image Figure 16. Global Propofol Injection for Operation General Anesthesia Revenue Share by Manufacturers in 2025 Figure 17. Global Manufacturers of Propofol Injection for Operation General Anesthesia, Manufacturing Sites & Headquarters Figure 18. Global Top 5 and 10 Propofol Injection for Operation General Anesthesia Players Market Share by Revenue in 2025 Figure 19. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global Propofol Injection for Operation General Anesthesia Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 21. Global Propofol Injection for Operation General Anesthesia Sales by Region in 2025 Figure 22. Global Propofol Injection for Operation General Anesthesia Revenue by Region in 2025 Figure 23. North America Propofol Injection for Operation General Anesthesia Market Size by Country in 2025 Figure 24. North America Propofol Injection for Operation General Anesthesia Sales Market Share by Country (2021-2032) Figure 25. North America Propofol Injection for Operation General Anesthesia Revenue Market Share by Country (2021-2032) Figure 26. United States Propofol Injection for Operation General Anesthesia Revenue Growth Rate (2021-2032) & (US$ Million) Figure 27. Canada Propofol Injection for Operation General Anesthesia Revenue Growth Rate (2021-2032) & (US$ Million) Figure 28. Mexico Propofol Injection for Operation General Anesthesia Revenue Growth Rate (2021-2032) & (US$ Million) Figure 29. Europe Propofol Injection for Operation General Anesthesia Market Size by Country in 2025 Figure 30. Europe Propofol Injection for Operation General Anesthesia Sales Market Share by Country (2021-2032) Figure 31. Europe Propofol Injection for Operation General Anesthesia Revenue Market Share by Country (2021-2032) Figure 32. Germany Propofol Injection for Operation General Anesthesia Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. France Propofol Injection for Operation General Anesthesia Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. U.K. Propofol Injection for Operation General Anesthesia Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Italy Propofol Injection for Operation General Anesthesia Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Russia Propofol Injection for Operation General Anesthesia Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Spain Propofol Injection for Operation General Anesthesia Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Netherlands Propofol Injection for Operation General Anesthesia Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Switzerland Propofol Injection for Operation General Anesthesia Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Sweden Propofol Injection for Operation General Anesthesia Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. Poland Propofol Injection for Operation General Anesthesia Revenue Growth Rate (2021-2032) & (US$ Million) Figure 42. Asia Pacific Propofol Injection for Operation General Anesthesia Market Size by Country in 2025 Figure 43. Asia Pacific Propofol Injection for Operation General Anesthesia Sales Market Share by Country (2021-2032) Figure 44. Asia Pacific Propofol Injection for Operation General Anesthesia Revenue Market Share by Country (2021-2032) Figure 45. China Propofol Injection for Operation General Anesthesia Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. Japan Propofol Injection for Operation General Anesthesia Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. South Korea Propofol Injection for Operation General Anesthesia Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. India Propofol Injection for Operation General Anesthesia Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Australia Propofol Injection for Operation General Anesthesia Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Taiwan Propofol Injection for Operation General Anesthesia Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. Southeast Asia Propofol Injection for Operation General Anesthesia Revenue Growth Rate (2021-2032) & (US$ Million) Figure 52. Southeast Asia Propofol Injection for Operation General Anesthesia Revenue Growth Rate (2021-2032) & (US$ Million) Figure 53. South America Propofol Injection for Operation General Anesthesia Market Size by Country in 2025 Figure 54. South America Propofol Injection for Operation General Anesthesia Sales Market Share by Country (2021-2032) Figure 55. South America Propofol Injection for Operation General Anesthesia Revenue Market Share by Country (2021-2032) Figure 56. Brazil Propofol Injection for Operation General Anesthesia Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Argentina Propofol Injection for Operation General Anesthesia Revenue Growth Rate (2021-2032) & (US$ Million) Figure 58. Chile Propofol Injection for Operation General Anesthesia Revenue Growth Rate (2021-2032) & (US$ Million) Figure 59. Middle East and Africa Propofol Injection for Operation General Anesthesia Market Size by Country in 2025 Figure 60. Middle East and Africa Propofol Injection for Operation General Anesthesia Sales Market Share by Country (2021-2032) Figure 61. Middle East and Africa Propofol Injection for Operation General Anesthesia Revenue Market Share by Country (2021-2032) Figure 62. Egypt Propofol Injection for Operation General Anesthesia Revenue Growth Rate (2021-2032) & (US$ Million) Figure 63. South Africa Propofol Injection for Operation General Anesthesia Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. Israel Propofol Injection for Operation General Anesthesia Revenue Growth Rate (2021-2032) & (US$ Million) Figure 65. Türkiye Propofol Injection for Operation General Anesthesia Revenue Growth Rate (2021-2032) & (US$ Million) Figure 66. GCC Countries Propofol Injection for Operation General Anesthesia Revenue Growth Rate (2021-2032) & (US$ Million) Figure 67. Global Propofol Injection for Operation General Anesthesia Sales Market Share by Type (2021-2032) Figure 68. Global Propofol Injection for Operation General Anesthesia Revenue Market Share by Type (2021-2032) Figure 69. Global Propofol Injection for Operation General Anesthesia Price (US$/unit) by Type (2021-2032) Figure 70. Global Propofol Injection for Operation General Anesthesia Sales Market Share by Application (2021-2032) Figure 71. Global Propofol Injection for Operation General Anesthesia Revenue Market Share by Application (2021-2032) Figure 72. Global Propofol Injection for Operation General Anesthesia Price (US$/unit) by Application (2021-2032) Figure 73. Propofol Injection for Operation General Anesthesia Value Chain Figure 74. Propofol Injection for Operation General Anesthesia Production Mode & Process Figure 75. Direct Comparison with Distribution Share Figure 76. Distributors Profiles Figure 77. Propofol Injection for Operation General Anesthesia Industry Opportunities and Challenges

Scope & coverage.

Types
  • 10ml
  • 20ml
  • 50ml
  • Others
Applications
  • Hopitals
  • Clinics
  • Others
Companies covered
  • Yichang Humanwell
  • Xi'an Libang
  • Nhwa
  • Hengrui
  • China National Medicines Guorui Pharmaceutical Co.,Ltd.
  • Fresenius-Kabi
  • Baxter Healthcare
  • AbbVie
  • AstraZeneca
  • Piramal
  • Maruishi
  • Hikma Pharmaceuticals
  • B.Braun
  • Aspen Pharma

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Propofol Injection for Operation General Anesthesia Market Size (2021-2032)
  4. 2.2.2 Global Propofol Injection for Operation General Anesthesia Sales (2021-2032)
  5. 2.2.3 Global Propofol Injection for Operation General Anesthesia Market Average Price (2021-2032)
  6. 2.3 Propofol Injection for Operation General Anesthesia by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 10ml
  9. 2.3.3 20ml
  10. 2.3.4 50ml
  11. 2.3.5 Others
  12. 2.4 Propofol Injection for Operation General Anesthesia by Application
  13. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  14. 2.4.2 Hopitals
  15. 2.4.3 Clinics
  16. 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Propofol Injection for Operation General Anesthesia Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Propofol Injection for Operation General Anesthesia Sales (k units) of Manufacturers (2021-2026)
  3. 3.3 Global Propofol Injection for Operation General Anesthesia Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Propofol Injection for Operation General Anesthesia Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Propofol Injection for Operation General Anesthesia Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Propofol Injection for Operation General Anesthesia, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Propofol Injection for Operation General Anesthesia, Product Type & Application
  8. 3.8 Global Manufacturers of Propofol Injection for Operation General Anesthesia, Established Date
  9. 3.9 Global Propofol Injection for Operation General Anesthesia Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Yichang Humanwell
  2. 4.1.1 Yichang Humanwell Company Information
  3. 4.1.2 Yichang Humanwell Business Overview
  4. 4.1.3 Yichang Humanwell Propofol Injection for Operation General Anesthesia Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Yichang Humanwell Propofol Injection for Operation General Anesthesia Product Portfolio
  6. 4.1.5 Yichang Humanwell Recent Developments
  7. 4.2 Xi'an Libang
  8. 4.2.1 Xi'an Libang Company Information
  9. 4.2.2 Xi'an Libang Business Overview
  10. 4.2.3 Xi'an Libang Propofol Injection for Operation General Anesthesia Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Xi'an Libang Propofol Injection for Operation General Anesthesia Product Portfolio
  12. 4.2.5 Xi'an Libang Recent Developments
  13. 4.3 Nhwa
  14. 4.3.1 Nhwa Company Information
  15. 4.3.2 Nhwa Business Overview
  16. 4.3.3 Nhwa Propofol Injection for Operation General Anesthesia Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Nhwa Propofol Injection for Operation General Anesthesia Product Portfolio
  18. 4.3.5 Nhwa Recent Developments
  19. 4.4 Hengrui
  20. 4.4.1 Hengrui Company Information
  21. 4.4.2 Hengrui Business Overview
  22. 4.4.3 Hengrui Propofol Injection for Operation General Anesthesia Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Hengrui Propofol Injection for Operation General Anesthesia Product Portfolio
  24. 4.4.5 Hengrui Recent Developments
  25. 4.5 China National Medicines Guorui Pharmaceutical Co.,Ltd.
  26. 4.5.1 China National Medicines Guorui Pharmaceutical Co.,Ltd. Company Information
  27. 4.5.2 China National Medicines Guorui Pharmaceutical Co.,Ltd. Business Overview
  28. 4.5.3 China National Medicines Guorui Pharmaceutical Co.,Ltd. Propofol Injection for Operation General Anesthesia Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 China National Medicines Guorui Pharmaceutical Co.,Ltd. Propofol Injection for Operation General Anesthesia Product Portfolio
  30. 4.5.5 China National Medicines Guorui Pharmaceutical Co.,Ltd. Recent Developments
  31. 4.6 Fresenius-Kabi
  32. 4.6.1 Fresenius-Kabi Company Information
  33. 4.6.2 Fresenius-Kabi Business Overview
  34. 4.6.3 Fresenius-Kabi Propofol Injection for Operation General Anesthesia Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Fresenius-Kabi Propofol Injection for Operation General Anesthesia Product Portfolio
  36. 4.6.5 Fresenius-Kabi Recent Developments
  37. 4.7 Baxter Healthcare
  38. 4.7.1 Baxter Healthcare Company Information
  39. 4.7.2 Baxter Healthcare Business Overview
  40. 4.7.3 Baxter Healthcare Propofol Injection for Operation General Anesthesia Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Baxter Healthcare Propofol Injection for Operation General Anesthesia Product Portfolio
  42. 4.7.5 Baxter Healthcare Recent Developments
  43. 4.8 AbbVie
  44. 4.8.1 AbbVie Company Information
  45. 4.8.2 AbbVie Business Overview
  46. 4.8.3 AbbVie Propofol Injection for Operation General Anesthesia Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 AbbVie Propofol Injection for Operation General Anesthesia Product Portfolio
  48. 4.8.5 AbbVie Recent Developments
  49. 4.9 AstraZeneca
  50. 4.9.1 AstraZeneca Company Information
  51. 4.9.2 AstraZeneca Business Overview
  52. 4.9.3 AstraZeneca Propofol Injection for Operation General Anesthesia Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 AstraZeneca Propofol Injection for Operation General Anesthesia Product Portfolio
  54. 4.9.5 AstraZeneca Recent Developments
  55. 4.10 Piramal
  56. 4.10.1 Piramal Company Information
  57. 4.10.2 Piramal Business Overview
  58. 4.10.3 Piramal Propofol Injection for Operation General Anesthesia Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Piramal Propofol Injection for Operation General Anesthesia Product Portfolio
  60. 4.10.5 Piramal Recent Developments
  61. 4.11 Maruishi
  62. 4.11.1 Maruishi Company Information
  63. 4.11.2 Maruishi Business Overview
  64. 4.11.3 Maruishi Propofol Injection for Operation General Anesthesia Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Maruishi Propofol Injection for Operation General Anesthesia Product Portfolio
  66. 4.11.5 Maruishi Recent Developments
  67. 4.12 Hikma Pharmaceuticals
  68. 4.12.1 Hikma Pharmaceuticals Company Information
  69. 4.12.2 Hikma Pharmaceuticals Business Overview
  70. 4.12.3 Hikma Pharmaceuticals Propofol Injection for Operation General Anesthesia Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Hikma Pharmaceuticals Propofol Injection for Operation General Anesthesia Product Portfolio
  72. 4.12.5 Hikma Pharmaceuticals Recent Developments
  73. 4.13 B.Braun
  74. 4.13.1 B.Braun Company Information
  75. 4.13.2 B.Braun Business Overview
  76. 4.13.3 B.Braun Propofol Injection for Operation General Anesthesia Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 B.Braun Propofol Injection for Operation General Anesthesia Product Portfolio
  78. 4.13.5 B.Braun Recent Developments
  79. 4.14 Aspen Pharma
  80. 4.14.1 Aspen Pharma Company Information
  81. 4.14.2 Aspen Pharma Business Overview
  82. 4.14.3 Aspen Pharma Propofol Injection for Operation General Anesthesia Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 Aspen Pharma Propofol Injection for Operation General Anesthesia Product Portfolio
  84. 4.14.5 Aspen Pharma Recent Developments
5 Global Propofol Injection for Operation General Anesthesia Market Scenario by Region
  1. 5.1 Global Propofol Injection for Operation General Anesthesia Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Propofol Injection for Operation General Anesthesia Sales by Region: 2021-2032
  3. 5.2.1 Global Propofol Injection for Operation General Anesthesia Sales by Region: 2021-2026
  4. 5.2.2 Global Propofol Injection for Operation General Anesthesia Sales by Region: 2027-2032
  5. 5.3 Global Propofol Injection for Operation General Anesthesia Revenue by Region: 2021-2032
  6. 5.3.1 Global Propofol Injection for Operation General Anesthesia Revenue by Region: 2021-2026
  7. 5.3.2 Global Propofol Injection for Operation General Anesthesia Revenue by Region: 2027-2032
  8. 5.4 North America Propofol Injection for Operation General Anesthesia Market Facts & Figures by Country
  9. 5.4.1 North America Propofol Injection for Operation General Anesthesia Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Propofol Injection for Operation General Anesthesia Sales by Country (2021-2032)
  11. 5.4.3 North America Propofol Injection for Operation General Anesthesia Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Propofol Injection for Operation General Anesthesia Market Facts & Figures by Country
  16. 5.5.1 Europe Propofol Injection for Operation General Anesthesia Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Propofol Injection for Operation General Anesthesia Sales by Country (2021-2032)
  18. 5.5.3 Europe Propofol Injection for Operation General Anesthesia Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Propofol Injection for Operation General Anesthesia Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Propofol Injection for Operation General Anesthesia Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Propofol Injection for Operation General Anesthesia Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Propofol Injection for Operation General Anesthesia Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Propofol Injection for Operation General Anesthesia Market Facts & Figures by Country
  41. 5.7.1 South America Propofol Injection for Operation General Anesthesia Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Propofol Injection for Operation General Anesthesia Sales by Country (2021-2032)
  43. 5.7.3 South America Propofol Injection for Operation General Anesthesia Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.8 Middle East and Africa Propofol Injection for Operation General Anesthesia Market Facts & Figures by Country
  48. 5.8.1 Middle East and Africa Propofol Injection for Operation General Anesthesia Market Size by Country: 2021 VS 2025 VS 2032
  49. 5.8.2 Middle East and Africa Propofol Injection for Operation General Anesthesia Sales by Country (2021-2032)
  50. 5.8.3 Middle East and Africa Propofol Injection for Operation General Anesthesia Revenue by Country (2021-2032)
  51. 5.8.4 Egypt
  52. 5.8.5 South Africa
  53. 5.8.6 Israel
  54. 5.8.7 Türkiye
  55. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Propofol Injection for Operation General Anesthesia Sales by Type (2021-2032)
  2. 6.1.1 Global Propofol Injection for Operation General Anesthesia Sales by Type (2021-2032) & (k units)
  3. 6.1.2 Global Propofol Injection for Operation General Anesthesia Sales Market Share by Type (2021-2032)
  4. 6.2 Global Propofol Injection for Operation General Anesthesia Revenue by Type (2021-2032)
  5. 6.2.1 Global Propofol Injection for Operation General Anesthesia Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Propofol Injection for Operation General Anesthesia Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Propofol Injection for Operation General Anesthesia Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Propofol Injection for Operation General Anesthesia Sales by Application (2021-2032)
  2. 7.1.1 Global Propofol Injection for Operation General Anesthesia Sales by Application (2021-2032) & (k units)
  3. 7.1.2 Global Propofol Injection for Operation General Anesthesia Sales Market Share by Application (2021-2032)
  4. 7.2 Global Propofol Injection for Operation General Anesthesia Revenue by Application (2021-2032)
  5. 7.2.1 Global Propofol Injection for Operation General Anesthesia Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Propofol Injection for Operation General Anesthesia Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Propofol Injection for Operation General Anesthesia Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Propofol Injection for Operation General Anesthesia Value Chain Analysis
  2. 8.1.1 Propofol Injection for Operation General Anesthesia Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Propofol Injection for Operation General Anesthesia Production Mode & Process
  5. 8.2 Propofol Injection for Operation General Anesthesia Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Propofol Injection for Operation General Anesthesia Distributors
  8. 8.2.3 Propofol Injection for Operation General Anesthesia Customers
9 Global Propofol Injection for Operation General Anesthesia Analyzing Market Dynamics
  1. 9.1 Propofol Injection for Operation General Anesthesia Industry Trends
  2. 9.2 Propofol Injection for Operation General Anesthesia Industry Drivers
  3. 9.3 Propofol Injection for Operation General Anesthesia Industry Opportunities and Challenges
  4. 9.4 Propofol Injection for Operation General Anesthesia Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst